Skip to search.
 TSX Up 0.60% TSX Ventures Up 1.02%

Amgen Inc. (AMGN)

-NasdaqGS
176.59 Up 4.90(2.85%) Jul 31, 4:00PM EDT
Add to Portfolio
Prev Close:171.69
Open:177.50
Bid:175.38 x 100
Ask:177.17 x 100
1y Target Est:183.25
Beta:0.65
Earnings Date:Oct 26 - Oct 30 (Est.)
Day's Range:176.00 - 181.81
52wk Range:124.81 - 181.81
Volume:7,289,406
Avg Vol (3m):3,288,980
Market Cap:134.27B
P/E (ttm):23.83
EPS (ttm):7.41
Div & Yield:3.16 (2.00%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AMGNUp 2.85%134.27B
JNJUp 0.37%277.89B
NVSUp 0.55%250.57B
TEVADown 0.07%58.53B

Key Statistics

Forward P/E (1 yr):16.53
P/S (ttm):6.34
Ex-Dividend Date:12-May-15

Analysts

Annual EPS Est (Dec-15) :9.72
Quarterly EPS Est (Sep-15) :2.36
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):1.53

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Amgen Inc., a biotechnology company, discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses for the treatment of illness in the areas of oncology, hematology, inflammation, bone health, nephrology, cardiovascular,... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback